Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F, Global Cancer Statistics 2020. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA. Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  Google Scholar 

Birnbaum JK, Duggan C, Anderson BO, Etzioni R. Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study. Lancet Glob Health. 2018;6:e885–93. https://doi.org/10.1016/S2214-109X(18)30257-2.

Article  PubMed  PubMed Central  Google Scholar 

Waks AG, Winer EP. Breast Cancer treatment: A review. JAMA. 2019;321:288–300. https://doi.org/10.1001/jama.2018.19323.

Article  CAS  PubMed  Google Scholar 

Wildiers H, Forceville K, Paridaens R, Joensuu H. Taxanes and anthracyclines in early breast cancer: which first? Lancet Oncol. 2010;11:219–20. https://doi.org/10.1016/S1470-2045(10)70025-5.

Article  PubMed  Google Scholar 

Andreopoulou E, Sparano JA. Chemotherapy in patients with anthracycline- and Taxane-Pretreated metastatic breast cancer: an overview, curr. Breast Cancer Rep. 2013;5:42–50. https://doi.org/10.1007/s12609-012-0097-1.

Article  CAS  Google Scholar 

Sparano JA. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials. Clin Breast Cancer. 2000;1:32–40. https://doi.org/10.3816/CBC.2000.n.002. discussion 41–42.

Article  CAS  PubMed  Google Scholar 

Shah AN, Gradishar WJ. Adjuvant anthracyclines in breast cancer: what is their role?? Oncologist. 2018;23:1153–61. https://doi.org/10.1634/theoncologist.2017-0672.

Article  PubMed  PubMed Central  Google Scholar 

Ji X, Lu Y, Tian H, Meng X, Wei M, Cho WC. Chemoresistance mechanisms of breast cancer and their countermeasures. Biomed Pharmacother. 2019;114:108800. https://doi.org/10.1016/j.biopha.2019.108800.

Article  CAS  PubMed  Google Scholar 

Cao J, Zhang M, Wang B, Zhang L, Zhou F, Fang M. Chemoresistance and metastasis in breast Cancer molecular mechanisms and novel clinical strategies. Front Oncol. 2021;11:1701. https://doi.org/10.3389/fonc.2021.658552.

Article  CAS  Google Scholar 

United Nations, THE 17 GOALS | Sustainable Development. 2025. https://sdgs.un.org/goals. Accessed May 20, 2025.

Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of Cancer drug resistance: A brief review. Adv Pharm Bull. 2017;7:339–48. https://doi.org/10.15171/apb.2017.041.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramos A, Sadeghi S, Tabatabaeian H. Battling chemoresistance in cancer: root causes and strategies to uproot them. Int J Mol Sci. 2021;22:9451. https://doi.org/10.3390/ijms22179451.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Zhan Q. The role of centrosomal Nlp in the control of mitotic progression and tumourigenesis. Br J Cancer. 2011;104:1523–8. https://doi.org/10.1038/bjc.2011.130.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao W, Song Y, Xu B, Zhan Q. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to Paclitaxel. Cancer Biol Ther. 2012;13:156–63. https://doi.org/10.4161/cbt.13.3.18697.

Article  CAS  PubMed  Google Scholar 

Marina M, Saavedra HI. Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance. Front Biosci Landmark Ed. 2014;19:352–65. https://doi.org/10.2741/4212.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schatten H. The mammalian centrosome and its functional significance. Histochem Cell Biol. 2008;129:667–86. https://doi.org/10.1007/s00418-008-0427-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bettencourt-Dias M, Q&A. Who needs a centrosome? BMC Biol. 2013;11:28. https://doi.org/10.1186/1741-7007-11-28.

Article  PubMed  PubMed Central  Google Scholar 

Nazockdast E, Redemann S. Mechanics of the spindle apparatus, Semin. Cell Dev Biol. 2020;107:91–102. https://doi.org/10.1016/j.semcdb.2020.06.018.

Article  CAS  Google Scholar 

Wu Q, Li B, Liu L, Sun S, Sun S. Centrosome dysfunction: a link between senescence and tumor immunity, signal transduct. Target Ther. 2020;5. https://doi.org/10.1038/s41392-020-00214-7.

Fu J, Hagan IM, Glover DM. The centrosome and its duplication cycle, cold spring Harb. Perspect Biol. 2015;7. https://doi.org/10.1101/cshperspect.a015800.

Krämer A, Neben K, Ho AD. Centrosome replication, genomic instability and cancer. Leukemia. 2002;16:767–75. https://doi.org/10.1038/sj.leu.2402454.

Article  PubMed  Google Scholar 

Jusino S, Fernández-Padín FM, Saavedra HI. Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity. J Cancer Metastasis Treat. 2018;4. https://doi.org/10.20517/2394-4722.2018.24.

Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell Polarity. Proc Natl Acad Sci. 1998;95:2950–5. https://doi.org/10.1073/pnas.95.6.2950.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhakta-Guha D, Saeed MEM, Greten HJ, Efferth T. Dis-organizing centrosomal clusters: specific cancer therapy for a generic spread? Curr Med Chem. 2015;22:685–94. https://doi.org/10.2174/0929867322666141212114529.

Article  CAS  PubMed  Google Scholar 

Ogden A, Rida PCG, Aneja R. Centrosome amplification: a suspect in breast cancer and Racial disparities. Endocr Relat Cancer. 2017;24:T47–64. https://doi.org/10.1530/ERC-17-0072.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Priyanga J, Guha G, Bhakta-Guha D. Microtubule motors in centrosome homeostasis: A target for cancer therapy? Biochim Biophys Acta Rev Cancer. 2021;1875:188524. https://doi.org/10.1016/j.bbcan.2021.188524.

Article  CAS  PubMed  Google Scholar 

Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P, Motors M. Mol. Biol. Cell 4th Ed. 2002. https://www.ncbi.nlm.nih.gov/books/NBK26888/. Accessed 22 Apr 2020.

Cooper GM. Microtubule Motors and Movements, Cell Mol. Approach 2nd Ed. 2000. https://www.ncbi.nlm.nih.gov/books/NBK9833/. Accessed 22 Apr 2020.

Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. Kinesin, Dynein, and Intracellular Transport, in: Mol. Cell Biol., 4th ed., W. H. Freeman, 2000. https://www.ncbi.nlm.nih.gov/books/NBK21710/. Accessed 20 Apr 2020.

Mallik R, Rai AK, Barak P, Rai A, Kunwar A. Teamwork in microtubule motors. Trends Cell Biol. 2013;23:575–82. https://doi.org/10.1016/j.tcb.2013.06.003.

Article  CAS  PubMed  Google Scholar 

Huo D, Yang H, Huang J-D, Cai J-P, Cui J. Roles of Kinesin superfamily proteins in colorectal cancer carcinogenesis (Review). Oncol Rep. 2021;46:1–10. https://doi.org/10.3892/or.2021.8072.

Article  CAS  Google Scholar 

Chen Q-H. Crosstalk between microtubule stabilizing agents and prostate Cancer. Cancers. 2023;15:3308. https://doi.org/10.3390/cancers15133308.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Lin Y, Long W, Yi R, Zhang X, Xie C, Jin N, Qiu Z, Liu X. The kinesin-14 family motor protein KIFC2 promotes prostate cancer progression by regulating p65. J Biol Chem. 2023;299. https://doi.org/10.1016/j.jbc.2023.105253.

Pan L, Zhang Y, Zhu C, Dong Z. Kinesin KIF4A is associated with chemotherapeutic drug resistance by regulating intracellular trafficking of lung resistance-related protein. J Zhejiang Univ Sci B. 2017;18:1046–54. https://doi.org/10.1631/jzus.B1700129.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yukuyama MN, de Souza A, Henostroza MAB, de Araujo GLB, Löbenberg R, de Faria R, de Souza GB, Guimaraes LMF, Lameu C, Folchini BR, Peroni CM, Oliveira IF, Miyagi MYS. Bou-Chacra, unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment. J Drug Deliv Sci Technol. 2023;89:105017.